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Background Information on prescribing practices in Palestine is lacking, however, still essential for strategic planning.
Purpose To characterise prescribing patterns and specific medicine use indicators in selected non-governmental organ-
isations’ (NGO) primary healthcare clinics/centres (PHC) in the West Bank (WB) in Palestine.
Methodology A prospective cross-sectional survey of prescribing practices based on medical records of 6032 patients with
acute symptoms frequenting 41 NGO PHCs in the WB, between July and September 2004. A systematic random sample of
every 10th patient appearing on the patient registration list was selected. Direct observation of consultation and dispensing
practices and times in a sub-group of patients was completed utilising special forms.
Results Respiratory tract infections were the most commonly occurring conditions. On average, 1.9 drugs were prescribed
per encounter and antibiotics were the most commonly prescribed medications, followed by Analgesics and NSAIDs
accounting for 46 and 20% of the total medications expenditures, respectively. Injections and combined medications use per
encounter was 16 and 8%, respectively. Most commonly prescribed medications were of local production. Consultation
(6.4 4.6minutes) and dispensing times (1.6 1.5minutes) were short with inadequate labelling. Provision of reference
sources and treatment guidelines implementation were also inadequate.
Conclusion The results suggest that prescribing practices could be improved through wider implementation of treatment
guidelines, a review of antibiotic prescribing, and increased time spent with patients to promote concordance. Strategies
aimed at improving prescribing and dispensing practices should be addressed through new innovative capacity building
models based on problem solving and feedback mechanisms. Copyright # 2008 John Wiley & Sons, Ltd.key words—prescribing patterns; medicine use indicators; rational use of medicine; quality of care; Palestine
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The promotion of rational use of medicines (RUM) is a
core component of the World Health Organisation’s*Correspondence to: R. Khatib, Institute of Community and Public
Health (ICPH), Birzeit University, PO Box 154, Ramallah, West
Bank, Palestine. E-mail: Rkhatib@birzeit.edu
Copyright # 2008 John Wiley & Sons, Ltd.(WHO) policy that all countries need to address. The
Palestinian health system is an embryonic one with
multiple complexities. Health services are provided
through four main actors: (a) the Ministry of Health
(the public sector), providing primary and secondary
care, with 56% of the population being covered by a
public health insurance scheme with minimal pre-
miums and high out-of-pocket payments to the private
1124 r. khatib ET AL.sector sometimes for quality care or care that is una-
vailable within this sector; (b) the non-governmental
organisations (NGOs), providing primary, secondary
and tertiary health care at low costs for all the
population; (c) the United Nations Relief and Works
Agency for Palestine Refugees in the Near East
(UNRWA), providing primary health care (PHC),
free-of-charge, to Palestinian refugees only; and (d)
the private sector, accessible to the better-off classes of
the population. The Palestinian Ministry of Health
(MOH) implemented the first essential drug list (EDL)
and EDL-Formulary in 2000 and 2002, respectively.
Procurement processes are now tied to the EDL and all
health workers at the MOH have received appropriate
training. In the NGOs, strong efforts were made to
rationalise the use of medications and each NGO has
its own EDL. Procurement and selling polices differ
between the various NGOs, where patients pay higher
prices for the medications prescribed than for
those available at the MOH but lower than for those
prescribed at the private sector. The impact of these
initiatives, however, on RUM has not been fully
evaluated, largely because of the prevailing unstable
political situation.
Existing evidence, mostly from the public sector,
indicates that irrational prescribing is an ongoing
problem in Palestine. Over-prescribing of antibiotics
and of non-steroidal anti-inflammatories (NSAIDs)
has been identified.1–3 Also, short consultation and
dispensing times have been reported, suggesting sub-
optimal patient management.1,3 Based on the WHO
medicine use indicators,4 the aim of this study is to
characterise prescribing patterns and provide infor-
mation relating to specific medicine use indicators in
NGO PHC clinics in the West Bank (WB). This will
provide much-needed baseline information on how to
develop strategies for improving medicine use across
all healthcare sectors.METHODS
Study setting and sample
A prospective cross-sectional survey was conducted in
the WB between July and September of 2004. A total
of 6032 patients’ records were selected out of 41 NGO
PHCs clinics. The clinics were conveniently selected
to include those visited as part of another project, in
order to facilitate access. Those clinics represented
different geographical location, type of care provision
and patient load. Every 10th patient appearing on the
patient registration list, with acute symptoms, wasCopyright # 2008 John Wiley & Sons, Ltd. Phasystematically selected by the attending physician/
nurse with 2–3 patients per day for a period of
3months (a minimum of 150 cases over 3months was
acceptable). The fieldworkers (research trained phar-
macists) visited the clinics on monthly basis and
monitored the sampling process. Patients were
selected from the 41 clinics in the first month.
Subsequently three clinics withdrew (one because of
internal administrative changes, one because the
physician in charge left the clinic, and one because
the physician declined to be monitored for the full
period). Data from these clinics was included in the
final analysis as no bias was evident.
The actual sample size was 6032 cases/patients
referred to from this point as ‘encounters’, in
accordance with theWHO indicators. It was important
to involve more encounters from more facilities than
WHO requires in order to obtain a full picture as
possible per individual NGO and to take into account
the likelihood of missing information in some
encounters.Data collection
Patient information. A prepiloted data collection
form was used to ensure that information was recorded
in as complete and consistent manner as possible,
given variable recording practices. The parameters
recorded from patients files were: name and file
number; sex; age; type of visit (first visit or follow-up);
main symptoms; diagnosis according to ICD10
(primary and secondary); medication(s) prescribed
(number, brand and generic names, dosage form,
strength, dosage, duration and cost price); specific
remarks/concerns about the patient (i.e. allergies,
pregnancy, chronic diseases, etc.). Medications
were categorised into their relative therapeutic
groups, according to BNF classification, as a
percent of the total prescribed medications in all the
encounters.Medicine use indicators
Prescribing indicators. Prescribing indicators for
6032 encounters—drawn primarily from the WHO
core medicine use indicators list4 (Box 1)—were
calculated from the collected forms mentioned
above, together with percentage of encounters with
analgesic and NSAIDs prescribed and cost. Country of
origin of the medications prescribed was also recordedrmacoepidemiology and Drug Safety, 2008; 17: 1123–1130
DOI: 10.1002/pds
MEDICINE UTILISATION REVIEW 1125as it may affect procurement policy and availability of
medications.CBox 1: Selected medicine use indicators
(WHO) used in this study.
Prescribing indicators:
1. Average number of medicines per counter¼
total medications prescribed/total number of
encounters.
2. Percentage of drugs prescribed by generic name¼
number of medications prescribed by generic
name/total prescribed medications 100%.
3. Percentage of encounters with antibiotic pre-
scribed¼ number of patients encounters given
antibiotics/total number of encounters 100%.
4. Percentage of encounters with injection pre-
scribed¼ number of patients encounters with
injections/total number of encounters 100%.Patient care indicators:
1. Average consultation time¼ total time for
several consultations/number of consultations.
2. Average dispensing time¼ total time for several
dispensing/number of dispensing encounters.
3. Percentage of drugs adequately labelled¼ num-
ber of drugs accurately labelled/total dispensed
100%.Health facility indicators:
1. Availability of copy of essential drugs list and
formulary¼ yes, no %.
2. Percentage of medicine costs spent on specific
therapeutic groups (antibiotics, NSAIDs).Complementary medicine use indicators
1. Average medicine cost per encounter.
2. Percentage of medicine costs spent on antibiotics.Patient care indicators. The fieldworkers used a
special checklist developed to directly observe a
selected sub-group of encounters from the larger
sample (every 3rd patient presenting at the time of
fieldworker’s visit) and recorded: physician consul-
tation time for 119 patients; dispensing time and
pharmacist counselling provided for 108 patients and
adequacy of written medication labelling was checked
upon exiting the clinic. Four criteria were checked and
considered adequate if 3/4 criteria met: patient name,
medication name, administration details and medicine
expiry date.opyright # 2008 John Wiley & Sons, Ltd. PhaHealthcare facility indicators. The fieldworkers
visited the 41 clinics and recorded the availability
(checked and seen) and usage of the EDL, a formulary,
specific disease treatment guidelines and general
medical references through directly asking the
practitioners about usage in addition to monitoring
during consultation. References older than 5 years
were not accounted for.
Data handling and analysis
The study was approved by the Institute of Com-
munity and Public Health Council, Birzeit University,
and the NGOs where the study was completed.
Permission to conduct the study was granted from the
various parent organisations and/or the clinic head
physician. All study participants were provided with
written information regarding the study objectives and
methodology.
Written instructions on completing the form were
provided to practitioners. During monthly visits,
fieldworkers provided support, collected forms and
checked completeness and validity of data (random
sample of forms checked against original records).
Patient names were removed from final records to
ensure anonymity and information was stored in a
password-protected database to ensure confidentiality
of all patient and healthcare staff information.
Cost calculations were based on cost price and expres-
sed in New Israeli Shekel (NIS, 1 USD¼ 4.5 NIS).
Data were coded, entered into a database (SPSS v15),
analysed using descriptive statistics and presented as
numbers, frequencies or proportions as appropriate,
with central tendency as mean and/or median.
RESULTS
Patient information
Demographic data. Results are presented from
6032 patient encounters. The percentage of women
(51%) and children under the age of 15 (48%) was
consistent between all clinics with average age of
27 10.2 years and in accordance with the demo-
graphic structure of the Palestinian population.5
Eighty nine percent of encounters were a first visit,
9% were a first follow-up (within 1week) and 2%
repeat follow-up for an acute condition.
Diagnosis. Respiratory tract infections (upper 31%
and lower 5%) were the most commonly occurring
conditions, with pharyngitis making up 17%, unspe-
cified upper respiratory tract infections 6%, otitis
media 4% and bronchitis 3% of respiratory tractrmacoepidemiology and Drug Safety, 2008; 17: 1123–1130
DOI: 10.1002/pds
Figure 1. The top 10 prescribed antibiotics in all encounters with
their average cost in NIS (n¼ 3760)
1126 r. khatib ET AL.infections. Other conditions included musculoskeletal
10%, non-infected dermatological 9%, and urinary
tract infections 8%, of all cases.
Medications prescribed. A total of 11 570 medi-
cations were prescribed for the selected encounters, of
which 11 426 were analysed (76—details not
recorded; 68—illegible) according to therapeutic
category (Table 1). Antibiotics accounted for 33%
of all medications and were mostly wide spectrum
antibiotics (amoxicillin, cephalexin, co-amoxiclav
and cotrimoxazole) of which co-amoxiclav comprises
the highest cost (Figure 1). Others were a mix of first,
second and third generation antibiotics. Antibiotics
(37%) were prescribed for children under 5 years and
about 15% for patients with infections of likely viral
origin (bronchitis, influenza, common cold).
Analgesics and anti-inflammatory agents accounted
for 29% of the total prescribed medications and
paracetamol, diclofenac and ibuprofen were pre-
scribed most commonly. Corticosteroids made up a
further 6% and other classes constituted the remaining
32% (Table 1).
The drugs most commonly administered by injec-
tion were dexamethasone and diclofenac given in a
single dose for the relief of acute pain, arthritis, muscle
or joint pain. Combined medications (containing more
than one active ingredient) were prescribed in 8% of
the encounters and included GI medications (3%),
dermatological (1.6%), analgesic/muscle relaxants
(1.1%), anti-cough preparations (1%).Medicine use indicators
Prescribing indicators. No medication was pre-
scribed in 303/6032 encounters (5%), 290 of whom
were referred to other specialists, admitted to hospital
or underwent minor medical procedures such as
dressing or casting.Table 1. Therapeutic classes of prescribed medications in the West
Therapeutic classes Value (%) (N¼ 11 426)
Antibiotics 33
Analgesics and NSAIDs 29
Corticosteroids 6
Anti-amoebic/anthelmintics 4
Anti-histamines 3
GI medications 3
Asthma medications 3
Others 19
Others include: multivitamins, dermatologicals, anaesthetics, antisepti
Copyright # 2008 John Wiley & Sons, Ltd. PhaThe average number of drugs prescribed per encounter
was 1.9þ 1.1, with an average cost of 25.1þ 14.9 NIS
(about $5) (Table 2). Generic prescribing represented
24% of all medications prescribed, mainly amox-
icillin, diclofenac and paracetamol. Antibiotics were
prescribed in 59% of encounters, with more than one
antibiotic prescribed in 3% of encounters and
antibiotics accounted for 46% of total medicine costs.
Analgesics and NSAIDS were prescribed in 48% of
encounters, accounting for 20% of medicine costs.
Medication administered by injection was prescribed
in 16% of encounters with only 4% out of these
injections were antibiotics (Pen VK as prophylactic).
Analysis of those indicators per NGO was consistent
with the general results and was shared and discussed
with each NGO administration and staff individually.
Patient care indicators. The average consultation
time was 6minutes (range 2–15minutes, n¼ 119
patients) and average dispensing time 1.7minutes
(range 0.5–3minutes, n¼ 108) (Table 3). Labelling ofBank
Most commonly prescribed medications
Amoxicillin, cephalexin, cotrimoxazole, co-amoxilav
Paracetamol, diclofenac Na; ibuprofen
Dexamethoasone, prednisone
Metronidazole
Chlorphineramine, promethazine
Ranitidine, ORS
Salbutamol
—
cs, sedatives and hypnotics, anti-convulsants, combined medications.
rmacoepidemiology and Drug Safety, 2008; 17: 1123–1130
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Table 4. Health facility indicators in the 41 clinics participated in
the study
Health facility indicator %
Availability of EDL (n¼ 41) 45
Availability of medical references (n¼ 41) 81
Usage of medical references (n¼ 33) 91
Availability of treatment guidelines (n¼ 41) 50
Usage of treatment guidelines (n¼ 20) 68
Table 2. Prescribing indicators in the study, 6032 encounters
based on patients’ records
Prescribing indicator Value
Average number of medicines
per encounter (N¼ 6032)
1.9þ 1.1
Cost per encounter (NIS) (N¼ 6032)
Meanþ SD 25.1þ 14.9
Median 19
% Generic prescribing (n¼ 11 570) 24
% Encounters antibiotic prescribed
(n¼ 6032)
59
% Medicine costs on antibiotics (n¼ 11 426) 46
% Encounters with> 1 antibiotic
prescribed (N¼ 6032)
3
% Encounters with injection
prescribed (n¼ 6032)
16
% Encounters with analgesic/NSAID prescribed
(N¼ 6032)
48
% Medicine costs on analgesics/NSAIDs
(N¼ 11 426)
20
N¼ number of encounters.
n¼ number of prescribed medications (missing data on 144 drugs).
NIS: New Israeli Shekel.
MEDICINE UTILISATION REVIEW 1127the dispensed medications was considered adequate in
only 60% of encounters and the details most often
omitted were patient name and medicine expiry dates.
Medication use was always written and expressed
numerically (e.g. 1 3). Upon excluding the expiry
date from analysis, 50% of the medications dispensed
were adequately labelled with the other three criteria
(name of the patient, name of the medication and
usage). Counselling during consultation and/or dis-
pensing was minimal, and generally confined to very
basic instructions for use (e.g. ‘one tablet three times
daily’).
Health facility indicators. From the 41 clinics
participated in the study, 45% had an EDL and were
operated jointly with the MOH or were part of a largerTable 3. Patient care indicators in the observed patients (119
consultations, 108 dispensing encounters)
Patient care indicator Value
Consultation time (minute, n¼ 119)
Meanþ SD 6.4þ 4.6
Median 5.0
Dispensing time (minute, n¼ 108)
Meanþ SD 1.7þ 1.5
Median 1.1
% Patients receiving drugs adequately labelled
(n¼ 108)
60
With three out of four criteria being adhered to: name of the patient,
name of the medication, usage, expiry date.
Copyright # 2008 John Wiley & Sons, Ltd. PhaNGO. However, even where present, the EDL was not
expressed as the generic medicine name and was used
only for purchasing orders.
In most clinics, the only reference source available
was that provided at the field visits.6 Only half of the
clinics had access to treatment guidelines or protocols,
and around two-thirds of those with access stated that
they were used in practice (Table 4).
Local production sources accounted for 77% of the
drugs prescribed, the remainder being of Israeli (12%)
or international origin (11%). The top 10 prescribed
medications for acute cases are produced locally such
as amoxicillin, cephalexin, co-amoxiclav, cotrimox-
azole, paracetamol, diclofenac Sod, Ibuprofen, dexa-
methasone, salbutamol and metronidazole. Primary
cost analysis for the most commonly prescribed
medications showed that the average cost for local
products was lower than the other sources (Table 5).
DISCUSSION
This is the first study conducted in the WB at the
NGOs primary care level describing patients frequent-
ing clinics for acute cases/symptoms. Patients with
chronic diseases such as CVD and diabetes attend to
specialty clinics with separate registration files to
facilitate follow-up and medication dispensing pro-
cess. The study sample of 6032 acute encounters
exhibited demographics, conditions and medicines
prescribed, consistent with reports describing the
public sector in Palestine and other countries.2,3,7–9Table 5. Average cost of selected most commonly prescribed
medications according to type of production in NIS
Medication
prescribed
Local
(NIS)
International
(NIS)
Israeli
(NIS)
Amoxicillin 8.8 9.2 13.6
Co-amoxiclav 23.6 30.8 27.2
Cephalexin 17.3 34.2 14.3
Diclofenac Sod 8.8 13.5 10.0
Paracetamol 4.9 5.6 7.4
1 NIS¼ 4.5$
rmacoepidemiology and Drug Safety, 2008; 17: 1123–1130
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1128 r. khatib ET AL.Infections were the most common presenting con-
dition; particularly respiratory tract infection followed
by musculoskeletal and dermatological disorders to a
lesser extent. This morbidity pattern was similar to the
annual reports published by those NGOs reflecting the
high prescribing patterns for antibiotics, analgesics
and anti-inflammatories.
Upon comparing the obtained results with similar
studies from other developing and developed countries
where high prevalence of patients with acute
symptoms are frequenting general clinics with a main
complaint of respiratory infections, the mean number
of medications prescribed of 1.9, was somewhat lower
than what was reported in a number of other similar
studies (Uzbekistan 2.9, Jordan 2.3, Cambodia 2.3,
Burkina Faso 2.3, Iran 4.4, Pakistan 4.1, India
3.2).8,10–15 This indicates lower poly-pharmacy and
possible adherence to some of the RUM concepts.
Generic prescribing was lower than reported in other
countries (Uzbekistan 38%; Cambodia 99.8% and
India 46%),8,11,15 although physicians are aware of its
importance, yet, quality of available generics remain
questionable to them. Moreover, enforcement of
generic prescribing is inadequate. Therefore, generic
prescribing should be actively promoted to facilitate
rational and cost-effective prescribing practices
through addressing the above-mentioned points.
Medication costs appear low, but these were based
on the cost price and do not reflect the selling price to
the patient, but the cost to the country as part of the
GDP spent on health. Given the current high levels of
unemployment (26%)5 and poverty (67%) in Pales-
tine,16 medicine costs are likely to present a significant
financial burden to patients.
Antibiotics were the most commonly prescribed
therapeutic class, as reported in other countries
where high prevalence of infection was
reported.10,11,13,15,17,18 Over-prescribing was evident
particularly for children and in cases where the
infection was of likely viral origin with common
prescribing of the first generation and wide-spectrum
antibiotics, which are locally produced and less
expensive than others, such as amoxicillin, cephalexin
and cotrimoxazole, as described in Iran, USA and
Croatia.13,18,19 Second generation antibiotics (co-
amoxiclav and ciprofloxacin) use was relatively high,
adding to costs and potentially affecting resistance
patterns.19,20 It is interesting to find that a second oral
antibiotic was never prescribed; and only in 3% of the
cases, only ointments and eye drops containing
antibiotics were prescribed instead. Factors affecting
the initial decision to prescribe (e.g. patient pressure to
prescribe and patients expectations,21,22 patientCopyright # 2008 John Wiley & Sons, Ltd. Phaload—where it is easier and faster to prescribe to
end the consultation,23 and physician–patient relation-
ship)24,25 and subsequent selection of antibiotic
require further research before a decision is made to
limit antibiotic prescribing. Most importantly,
microbial resistance patterns for the most commonly
prescribed antibiotics should be identified in Palestine.
This would facilitate developing evidence-based
treatment guidelines.
Analgesics and NSAIDs were generally prescribed
with other medication as reported locally26 and
internationally.9,27 Although this use was considered
low compared to adjacent countries such as Saudi
Arabia (51%) and Iran (63%)9,13 still there is a room
for further reduction in utilisation, provided appro-
priate diagnosis confirmed. It is important to analyse
‘what was prescribed’ against the ‘identified diag-
nosis’ if wewould promote rational use of medications
and support developing new policies that would
change practices. Corticosteroid preparations were
also used commonly as first-line medication, generally
in combination with diclofenac sodium injections, for
all types of pain, including toothache. It is unlikely
that such use of corticosteroids can be justified and
may lead to masking of symptoms.26 The use of
combined preparations was lower than reported
elsewhere15 and the use of injection at those clinics
was considered low compared to other
countries8,13,14,17 but still higher compared to other
developing countries.10,11,15 This somewhat low use of
combined medications and injections could be
explained by the ‘transfer effect’ of some regulations
at the public sector limiting the use of these dosage
forms at the primary care level unless for specific
indication. However, ways of minimising the use of
these categories need to be explored further.
The high level of use of medicines produced locally,
which is also found to be cheaper, is encouraging and
should help facilitate evidence-based medicine that is
also cost-effective along with focusing on the
guidelines implementation for the identified acute
cases in this study.
Consultation and dispensing times were found to be
very short, although longer than what is reported
locally in the public sector clinics with similar case
load (1–2minutes for consultation and less than
1minute for dispensing).1,3 Similar findings were
reported in Cambodia11 and Jordan.28 In India,15
consultation time was shorter; however, this has been
compensated for with longer dispensing time. Short
time spent with the patient may contribute to sub-
optimal patient management leading to reduced
quality of care provided and could lead to multiplermacoepidemiology and Drug Safety, 2008; 17: 1123–1130
DOI: 10.1002/pds
KEYPOINTS
 Medicine use indicators at the NGOs clinics in
Palestine showed sub-optimal practices in
medications prescribing, consultation and dis-
pensing with over-prescribing of antibiotics
followed by analgesics and NSAIDs accounting
for 46 and 20% of the total medications
expenditures, respectively.
 Utilising the Ministry of Health EDL and
formulary to develop and unify the various
EDLs available at each NGO.
 Advanced training on RUM including medicine
management cycle and logistics is required to
focus on prescribing, dispensing and patients’
indicators. This capacity building program
should focus on the most commonly used/
overused medications such as antibiotics and
NSAIDs.
 Devising a reporting/registration system that
would facilitate reliable data collection for
medicine use indicators, which should also be
institutionalised through creating a platform for
sharing experiences and discussing the collected
indicators from various facilities. This would
improve practices and improve quality of care
provided.
 The need for a well-structured infield super-
vision based on problem solving and feedback
mechanisms to implement proposed strategies
for improvement.
MEDICINE UTILISATION REVIEW 1129re-consultations. In addition, short counselling times,
could affect patient satisfaction leading to further
‘shopping around’ for health care at other healthcare
providers.24,29,30 Clear, standardised and focused
messages on usage, possible interactions and side
effects should be given to patients during consultation
and dispensing. Appropriate labelling of medications
dispensed is essential for patient adherence to
treatment, however, this study showed that labelling
practices were not adequate which, from observation,
could be due to patient over-load and unavailability of
the dispensing paper bags where appropriate infor-
mation/instructions could be written.
It has to be mentioned that this study indicated that
routinely collected patients’ records could be useful
for retrospective surveys provided the implementation
of a unified and complete filing systems. These
findings also provide evidence of the need to
implement strategies and treatment guidelines to
regulate prescribing and dispensing practices, especi-Copyright # 2008 John Wiley & Sons, Ltd. Phaally for antibiotics. Schemes should be devised to
promote longer patient consultation, possibly through
widening professionals’ knowledge in counselling and
introducing an appointment system. Implementation
of new strategies could be achieved through applying
appropriate infield training programs associated with
user friendly monitoring and supervision tools.
The prospective study may be biased due to ‘the
Hawthorn effect’ but this is likely to diminish over
time. Moreover, examination of a small retrospective
sample from the records showed the same trends. Even
if there was an observational bias and increase
awareness of prescribers and dispensers for RUM
practices through the monthly visits, over-prescribing
was evident and the true extent of this is likely to be
worse than observed. The study sample size was
limited by the withdrawal of three clinics after
1month, but there was no evidence of under-
representation of particular patient, disease or
medications sub-groups. Another limitation was
missing or poor hand-written data, but this affected
a very small proportion of the data and is common in
this type of studies.9,31 Results obtained in this study
should not be generalised to other types of health
facilities or NGOs not participating in this study,
although previous work in the public sector showed
same trends in over prescribing and similar top ten
prescribed medications. Moreover, it is important to
note that seasonal variations were not examined as
data collection was restricted to 3months of the year
only, however, and concerning antibiotic use specifi-
cally, the high prescribing patterns detected during
summer could indicate a much higher prescribing
patterns during winter.
In conclusion, in this large cross-sectional survey of
prescribing for acute conditions, respiratory tract
infection was the most common condition treated and
this was reflected in the high number and cost of
antibiotics prescribed. There was considerable evi-
dence of sub-optimal prescribing practices, with little
application of individual NGO EDL and formulary,
lack of use of evidence-based treatment guidelines and
lack of time spent in consultation and dispensing.
Strategies to improve medicine use are urgently
required to avoid waste of scarce resources and to
optimise patient care and the overall quality of
healthcare in the WB. Study results have already been
disseminated through a series of workshops to get
consensus on the key findings and to identify areas
needed for change in practice. A robust filing and
reporting system accompanied with capacity building
activities based on problem solving and feedback
mechanisms are essential to underpin current practices.rmacoepidemiology and Drug Safety, 2008; 17: 1123–1130
DOI: 10.1002/pds
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